Core Stabalization and Rebound Therapy and CP
Launched by CAIRO UNIVERSITY · Feb 13, 2023
Trial Information
Current as of May 01, 2025
Unknown status
Keywords
ClinConnect Summary
PURPOSE:
To compare the effect of core stabilization and rebound therapy on balance in children with hemiplegic cerebral palsy
BACKGROUND:
Cerebral palsy is primarily a disorder of movement and posture
HYPOTHESES:
There is no significant difference between core stabilization and rebound therapy on balance in children with hemiplegic cerebral palsy.
RESEARCH QUESTION:
Is there a significant difference between core stabilization and rebound therapy on balance in children with hemiplegic cerebral palsy?
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • children diagnosed with spastic hemiplegic CP.
- • Their chronological age ranged from 5 to 8 years,
- • able to follow verbal commands or instructions during testing procedures,
- • degree of spasticity in affected lower limbs ranged between1 to 1+ according to Modified Ashworth scale (MAS),
- • they are able to understand and follow instructions given to them,
- Exclusion Criteria:
- • Children who had significant visual or auditory problems that may interfere with testing, - ---- patients who had contractures or fixed deformities related to the joints of the lower limbs, ---- injection with Botulinium toxin or any orthopaedic surgery in lower limbs 6m before study,
- • children who were suffering from cardiopulmonary problems or epilepsy.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Faculty OP Therapy
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials